Skip to main content

ONWRY · Onward Medical N.V./ADR · Off Exchange

Track ONWRY — free
$3.15 At close · Sep 9

Weekly off-exchange (dark pool / OTC) trading volume reported to FINRA under its OTC/ATS Transparency data. ATS volume is executed on alternating trading systems (dark pools); non-ATS OTC is other over-the-counter dealer volume. The off-exchange share is total off-exchange volume as a percentage of consolidated weekly trading volume for the same Monday–Friday week.

Off-Exchange Volume History

Week Start ATS Volume Non-ATS OTC Volume Total Off-Exchange % of FINRA Weekly Volume
2026-08-10 0 35,111 35,111 100.0%
2026-08-03 0 17,889 17,889 100.0%
2026-07-27 0 79,175 79,175 100.0%
2026-07-20 0 38,634 38,634 100.0%
2026-07-13 0 27,742 27,742 100.0%
2026-07-06 0 1,489 1,489 99.3%
2026-06-29 0 1,379 1,379 98.5%
2026-06-22 0 16,636 16,636 100.0%
2026-06-15 0 668 668 100.0%
2026-06-08 0 1,035 1,035 100.0%
2026-06-01 0 4,998 4,998 100.0%
2026-05-25 0 1,138 1,138 100.0%
2026-05-18 0 1,475 1,475 98.3%
2026-05-11 835 2,763 3,598 99.9%
2026-05-04 0 1,033 1,033 100.0%
2026-04-27 0 2,284 2,284 99.3%
2026-04-20 0 2,544 2,544 100.0%
2026-04-13 0 3,750 3,750 98.7%
2026-04-06 0 780 780 97.5%
2026-03-30 300 752 1,052 95.6%
2026-03-23 0 5,293 5,293 99.9%
2026-03-16 0 1,711 1,711 95.1%
2026-03-09 5,000 1,200 6,200 100.0%
2026-03-02 0 4,202 4,202 100.0%
2026-02-23 0 5,301 5,301 100.0%
2026-02-16 0 2,000 2,000 100.0%
2026-02-09 0 300 300 100.0%
2026-02-02 0 4,234 4,234 100.0%
2026-01-26 0 5,583 5,583 99.7%
2026-01-19 0 2,890 2,890 99.7%
2026-01-12 0 2 2
2026-01-05 0 286 286 95.3%
2025-12-29 0 233 233 100.0%
2025-12-15 0 661 661 94.4%
2025-12-08 0 235 235 100.0%
2025-12-01 0 1,120 1,120 100.0%
2025-11-24 0 305 305 100.0%
2025-11-17 0 1,800 1,800 94.7%
2025-11-10 0 20,595 20,595 100.0%
2025-11-03 1,000 1,010 2,010 100.0%
2025-10-27 0 3,683 3,683 99.5%
2025-10-20 102 3,607 3,709 100.0%
2025-10-13 0 20 20
2025-10-06 0 1,481 1,481 98.7%
2025-09-29 0 805 805 100.0%
2025-09-22 0 304 304 100.0%
Showing 1–46 of 46 weeks
Key facts CIK 2059986 CUSIP 68339U102 Visit website Investor relations